The fertility and pregnancy rapid test kit market size was valued at US$ 948.3 million in 2022. By the end of 2023, the industry is likely to reach a valuation of US$ 990.4 million. During the forecast period, the industry for fertility and pregnancy rapid test kit is expected to garner a 5% CAGR and reach US$ 1,609.1 million by 2033.
Key Industry Trends and Highlights
| Attributes | Details |
|---|---|
| Estimated Market Value in 2022 | US$ 948.3 million |
| Expected Market Value in 2023 | US$ 990.4 million |
| Expected Market Value in 2033 | US$ 1,609.1 million |
| Value-based CAGR from 2023 to 2033 | 5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The fertility and pregnancy rapid test kit market expanded at a 4% CAGR during the historical period.
| Report Attributes | Details |
|---|---|
| Market value in 2018 | US$ 810.1 million |
| Market value in 2022 | US$ 948.3 million |
| CAGR from 2018 to 2022 | 4% |
The increased rate of infertility is one of the key factors propelling the growth of the global industry for fertility and pregnancy rapid test kit over the projected time frame. For example, in August 2021, the National Survey of Family Growth found that the percentage of infertile women in the 15-34 age group ranged from 7.3% to 9.1%.
The incidence of infertility among women aged 35 to 39 rose to 25%. There was a 30% likelihood of infertility for women between the ages of 40 and 44. Increasing infertility rates as such are boosting the global demand for fertility and pregnancy rapid test kit.
The growing awareness about family planning also rose during the historical period. This pandemic has increased awareness regarding the significance of reproductive health since many couples delayed having children for personal or medical reasons. Factors like these propelled the growth in the industry from 2018 to 2022.
Principal Consultant
The table below lists the top five nations projected to experience significant growth during the forecast period. The United States and China are predicted to have the maximum development among these nations.
Forecast CAGRs from 2023 to 2033
| Country | CAGR from 2023 to 2033 |
|---|---|
| The United States | 5.2% |
| China | 6% |
| France | 4.1% |
| Japan | 4.7% |
| The United Kingdom | 4.9% |
The fertility and pregnancy rapid test kit market in the United States is expected to garner a 5.2% CAGR during the forecast period.
The United States confronts issues with healthcare affordability and accessibility, and a large number of people are looking for low-cost methods of managing their reproductive health. An easy and cost-effective way to keep track of fertility and pregnancy status is by using an at-home fertility and pregnancy rapid test kit.
Demand for rapid test kit has surged in the United States due to delayed family planning and shifting demographic patterns. These test kits assist people in making educated decisions on having children as numerous people prioritize their education and employment.
The market in China for fertility and pregnancy rapid test kit is likely to expand with a 6% CAGR from 2023 to 2033.
The former one-child restriction and the sizable population of China have led to a high demand for fertility and pregnancy rapid test kit. Interest in these kits has risen due to the one-child ban being loosened and family planning has become increasingly important.
In China, rapid urbanization, lifestyle changes, and several women joining the service sector have contributed to postponed motherhood. The market for these test kits is expanding due to the increasing need for family planning and fertility monitoring.
The fertility and pregnancy rapid test kit market in France is likely to garner a 4.1% CAGR from 2023 to 2033.
Healthcare consumerism and personal responsibility are equally highly valued. This promotes self-management of reproductive health by providing fertility and pregnancy test kit that people may use at home.
Personal privacy is highly valued in French society, especially regarding health issues. The discrete method that at-home test kits provide for tracking fertility and pregnancy in individuals and couples aligns with cultural norms and propels market expansion.
The fertility and pregnancy rapid test kit market in Japan is estimated to accelerate with a 4.7% CAGR during the forecast period.
Japan is experiencing a high than average rate of fertility issues along with delayed family planning. To assist people in managing their reproductive health, there is an increasing need for fertility and pregnancy rapid test kit.
Japan is renowned for its technical ingenuity and the healthcare industry is no exception. Manufacturers in Japan have produced sophisticated and precise pregnancy and fertility test kits, drawing in customers searching for dependable and superior products.
The United Kingdom fertility and pregnancy rapid test kit market is poised to expand with a 4.9% CAGR during the forecast period.
There are issues with the National Health Service in the United Kingdom, including overcrowding and long waiting times for medical attention. People are turning to at-home fertility and pregnancy test kit to keep an eye on their reproductive health quickly and conveniently.
In the United Kingdom, education about sexual and reproductive health is highly valued. People are now conscious of their reproductive health due to this educational focus. In turn, it has raised demand for fertility and pregnancy test kit to aid with family planning decisions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below highlights how the pregnancy rapid test kit is projected to lead the global industry by product type. This segment is expected to develop at a 4.6% CAGR during the forecast period.
The hCG urine test used for pregnancy detection has gained immense traction in the last few years. During the forecast period, the hCG urine test segment is likely to expand with a 4.2% CAGR.
| Category | CAGR from 2023 to 2033 |
|---|---|
| Pregnancy Rapid Test Kit by Product | 4.5% |
| hCG Urine Test by Test Type | 6.2% |
The pregnancy rapid test kit is anticipated to expand at a 4.5% CAGR during the forecast period. A rapid pregnancy test kit is an affordable way to track fertility and is used for family planning.
A rapid pregnancy test kit is accessible to a broad spectrum of people, including those with little financial means, because it is less expensive than clinical testing and seeing a doctor. Thanks to this cost-effective kit, people are empowered to take charge of their reproductive well-being and make sensible choices regarding family planning.
Pregnancy can be identified with several rapid test kit as early as a few days before the next menstruation cycle. Early pregnancy identification makes it possible for people to make informed decisions regarding prenatal treatment and lifestyle modifications at an early stage of the pregnancy.
Based on the test type, the hCG segment is anticipated to take up a significant global market share. The hCG test segment is likely to experience a 6.2% CAGR during the forecast period.
Pregnancy can be identified early on using hCG testing. Susceptible tests can detect hCG levels in blood or urine as early as a few days post-conception, frequently before irregular menstruation. Thanks to this early discovery, people can obtain timely prenatal treatment and make the required lifestyle modifications.
The hCG tests are also used clinically to monitor specific medical problems where excessive hCG levels may be a sign of concern. Given its adaptability, hCG tests are a useful diagnostic tool for obstetrics and other medical fields.
Developing consumer knowledge and preference for certain fertility and pregnancy test kit requires effective marketing and branding initiatives. Manufacturers spend money on advertising campaigns, social media marketing, and collaborations with medical experts to build trust and brand awareness. They could also provide discounts and promotions to promote product adoption and boost revenue and sales.
Prominent Developments by the Key Companies in the Market
| Company | Key Developments |
|---|---|
| Salignostics |
|
| Mankind Pharma |
|
| Mylab Discovery Solutions |
|
| Attributes | Details |
|---|---|
| Projected market value in 2023 | US$ 990.4 million |
| Projected market value in 2033 | US$ 1,609.1 million |
| Forecast CAGR from 2023 to 2033 | 5% |
| Forecast period | 2023 to 2033 |
| Historical period | 2018 to 2022 |
| Market analysis | Value in US$ million |
| Key regions covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
| Key countries profiled | The United States, Canada, Brazil, Mexico, Germany, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key market segments | Product, Test Type, Distribution channel, Region |
| Key companies profiled | Alere Inc.; Quidel Corporation; Prestige Brands Holdings, Inc.; Church & Dwight Co., Inc.; bioMérieux SA; Geratherm Medical AG; Abbott Laboratories; Procter & Gamble Co.; DCC Plc.; Swiss Precision Diagnostics GmbH |
Sales of fertility and pregnancy rapid test kit are expected to reach US$ 990.4 million by 2023.
By 2033, the fertility and pregnancy rapid test kit market is poised to rise at a 5% CAGR
The fertility and pregnancy rapid test kit market is forecast to reach US$ 1,609.1 million by 2033.
The pregnancy rapid test kit is projected to expand at a CAGR of 4.5% during the forecast period.
The hCG test category is anticipated to develop at a 6.2% CAGR through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Pregnancy Rapid Tests
5.3.1.1. Line-Indicator devices
5.3.1.2. Digital
5.3.2. Fertility Rapid Tests
5.3.2.1. Line-Indicator
5.3.2.2. Digital
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Test Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Test Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Test Type, 2023 to 2033
6.3.1. LH Urine
6.3.2. FSH Urine
6.3.3. hCG Blood
6.3.4. hCG Urine
6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033
7. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Distribution channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution channel, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution channel, 2023 to 2033
7.3.1. Pharmacy
7.3.2. Drugstore
7.3.3. Gynecology/Fertility Clinics
7.3.4. e-commerce
7.3.5. Hypermarkets & Supermarkets
7.4. Y-o-Y Growth Trend Analysis By Distribution channel, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Distribution channel, 2023 to 2033
8. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Test Type
9.2.4. By Distribution channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Test Type
9.3.4. By Distribution channel
9.4. Key Takeaways
10. Latin America Market 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Test Type
10.2.4. By Distribution channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Test Type
10.3.4. By Distribution channel
10.4. Key Takeaways
11. Western Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Test Type
11.2.4. By Distribution channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Test Type
11.3.4. By Distribution channel
11.4. Key Takeaways
12. Eastern Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Test Type
12.2.4. By Distribution channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Test Type
12.3.4. By Distribution channel
12.4. Key Takeaways
13. South Asia and Pacific Market 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Test Type
13.2.4. By Distribution channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Test Type
13.3.4. By Distribution channel
13.4. Key Takeaways
14. East Asia Market 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Test Type
14.2.4. By Distribution channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Test Type
14.3.4. By Distribution channel
14.4. Key Takeaways
15. Middle East and Africa Market 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Test Type
15.2.4. By Distribution channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Test Type
15.3.4. By Distribution channel
15.4. Key Takeaways
16. Key Countries Market
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Test Type
16.1.2.3. By Distribution channel
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Test Type
16.2.2.3. By Distribution channel
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Test Type
16.3.2.3. By Distribution channel
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Test Type
16.4.2.3. By Distribution channel
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Test Type
16.5.2.3. By Distribution channel
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Test Type
16.6.2.3. By Distribution channel
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Test Type
16.7.2.3. By Distribution channel
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Test Type
16.8.2.3. By Distribution channel
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Test Type
16.9.2.3. By Distribution channel
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Test Type
16.10.2.3. By Distribution channel
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Test Type
16.11.2.3. By Distribution channel
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Test Type
16.12.2.3. By Distribution channel
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Test Type
16.13.2.3. By Distribution channel
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Test Type
16.14.2.3. By Distribution channel
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Test Type
16.15.2.3. By Distribution channel
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Test Type
16.16.2.3. By Distribution channel
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Test Type
16.17.2.3. By Distribution channel
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Test Type
16.18.2.3. By Distribution channel
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Test Type
16.19.2.3. By Distribution channel
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Test Type
16.20.2.3. By Distribution channel
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Test Type
16.21.2.3. By Distribution channel
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product
16.22.2.2. By Test Type
16.22.2.3. By Distribution channel
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product
16.23.2.2. By Test Type
16.23.2.3. By Distribution channel
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Test Type
17.3.4. By Distribution channel
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Alere Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Quidel Corporation
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Prestige Brands Holdings, Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Church & Dwight Co., Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. bioMérieux SA
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Geratherm Medical AG
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Abbott Laboratories
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Procter & Gamble Co.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. DCC Plc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Swiss Precision Diagnostics GmbH
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Healthcare
June 2023
REP-GB-6108
342 pages
Explore Healthcare Insights
View Reports
Fertility and Pregnancy Rapid Test Kit Market
